The table below shows Cytek Biosciences, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$44.13M
$52.29M
$45.60M
$41.46M
$51.50M
$46.62M
Cost of revenue
$22.88M
$24.74M
$21.73M
$21.30M
$22.50M
$21.18M
Gross profit
$21.25M
$27.55M
$23.87M
$20.16M
$29.00M
$25.44M
R&D
$9.60M
$8.96M
$8.83M
$9.72M
$9.88M
$10.00M
CTKB annual revenue (10-K history)
Cytek Biosciences, Inc. reported annual revenue of $201.49M for fiscal year 2025. That is up 0.5% from $200.45M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $710.00K (FY 2020) to $201.49M. Figures come from the company's audited annual reports as filed with the SEC.